It also prevents the solution from sitting against the stopper seal, which can degrade faster than the glass walls of the vial
There was also a significant 26% relative risk reduction in the primary composite outcome (the first occurrence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke) in the semaglutide group compared to the placebo group
doi:10.1097/fbp.0000000000000818 16.Garvey WT, Blher M, Osorto Contreras CK, et al
Editorial refresh Practical 2026 note for Hims vs Ro vs Calibrate for GLP Hims vs Ro vs Calibrate for GLP now carries extra 2026 context around semaglutide, tirzepatide, cash-pay pricing, safety signals, hims, calibrate, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation
Dasgupta says